ELIZABETH RAMBO: Open Payments
NPI 1912991464 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 43 payments from 24 companies in 2025. Trend: 2023 $59 · 2024 $716 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $212 |
| PFIZER INC. | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Janssen Biotech, Inc. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| JAZZ PHARMACEUTICALS INC. | 1 | $31 |
| SK Life Science, Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: EPKINLY, VENCLEXTA, IBRANCE, ENHERTU, Vanflyta, KEYTRUDA, ZEPZELCA, TECVAYLI.
Industry payments across GA — which companies pay providers there.
